Resistencia a cefalosporinas en infecciones por Streptococcus pneumoniae

Medicina Clinica

Volumn 110, Issue SUPPL. 1, 1998, Pages 21-24

  Liñares, Josefina ^a   Tubau, Fe ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFDINIR; CEFEPIME; CEFETAMET; CEFIXIME; CEFONICID; CEFOTAXIME; CEFPIROME; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; PENICILLIN BINDING PROTEIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REVIEW; SPAIN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

CEPHALOSPORIN RESISTANCE; HUMANS; PNEUMOCOCCAL INFECTIONS; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 0031914782     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Jacobs MR, Koornhof HJ, Robins-Browne RM, Stevenson CM, Vermaak ZA, Freiman I et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978; 299: 735-740.
2. Klugman KP. Penumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-196.
3. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
4. Baquero F. Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Microbial Drug Resistance 1995; 1: 115-120.
5. Fenoll A, Martin-Bourgon C, Muñoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance in Streptococcus pneumoniae isolates producing systemic infections in Spain 1979-1989. Rev Infect Dis 1991; 13: 56-60.
6. Lin̄ares J, Pallarés R, Alonso T, Pérez JL, Ayats J, Gudiol F et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain 1979-1990. Clin Infect Dis 1992; 15: 99-105.
7. Lee HJ, Park JY, Jang SH, Kim JH, Kim EC, Choi KW. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university in Korea Clin Infect Dis 1995; 20: 826-835.
8. Lin̄ares J, Alonso T, Pérez JL, Ayats J, Dominguez MA, Pallarés R et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J Antimicrob Chemother 1992; 30: 279-288.
9. Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilities of 117 penicillin-susceptible and resistant pneumococci to Fk 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem and vancomycin. Antimicrob Agents Chemother 1994; 38: 898-900.
10. Spangler SK, Jacobs MR, Appelbaum PC. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penern, compares with those to penicillin G, amoxicillin, amoxicilli-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime and cefdinir. Antimicrob Agents Chemother 1994; 38: 2.902-2.904.
11. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40: 1.208-1.213.
12. Soriano F, Dosificacion ideal y pauta de administración de los antibióticos betalactámicos orales en el tratamiento de la infeccion neumocócica. Enferm Infecc Microbiol Clin 1993; 11 (Supl 1): 44-50.
13. Garau J. Actividad de las cefalosporinas trente a Streptococcus pneumoniae. Enferm Infecc Microbiol Clin 1993; 11 (Supl 1): 28-32.
14. Goldstein FW, Acar JF and The Alexander Project Collaborative Group Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 Western Europe and USA collaborative study. J Antimicrob Chemother 1996; 38 (Supl A): 71-84.
15. Liǹares J, Tubau F, Alcaide F, Ardanuy C, Garcia A, Martin R. Antimicrobial resistance of Streptococcus pneumonias: comparison of the in vitro activity of 16 antibiotics. Curr Ther Res 1996; 57 (Supl A): 57-64.
16. Hakenbeck R, Tarpay M, Tornasz A. Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1980; 17: 364-371.
17. Coffey TJ, Dowson CG, Daniels M, Spratt BG. Genetics and molecular biology of β-lactam-resistant pneumococci. Microbial Drug Resistance 1995; 1: 29-34.
18. Muñoz R, Dowson DG, Daniels M, Coffey CJ, Martin C, Hakenbeck C et al. Genetics of resistance to third-generation cephaiosporins in clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1992; 17: 2.461-2.465
19. Coffey TJ, Daniels M, McDougal K, Dowson CG, Tenover FC, Spratt BG. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob Agent Chemother 1995; 39: 1.306-1.313.
20. Reichmann P, König A, Liñares J, Alcaide F, Tenover FC, McDougal L et al. A global gene pool for high-level cephalosporin resistance in commensal Streptococcus spp and Streptococcus pneumoniae. J Infect Dis 1997; 176: 1.001-1.012
21. Leggiadro RJ, Barrett FF, Chesney PJ, Davis Y, Tenover FC. Invasive pneumococci with high level penicillin and cephalosporin resistance at a mid-south children's hospital. Pedriatr Infect Dis J 1994; 13: 320-322.
22. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: fifth Informational Supplement. NCCLS document M100-S5 (ISBN 1-56238-249-7). NCCLS, 771. Villanova Pa; NCCLS, 1994.
23. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibity to beta-lactam antibiotics. Pediatr Infect Dis J 1991; 10: 871-873.
24. Figueirido ASM, Connor JD, Severin A, Vaz-Pato MV, Tomasz A. A pneurnococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob Agents Chemother 1992; 36: 886-889.
25. John CC. Treatment failure with use of a third-generation cephalosporin for penicillir-resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994; 18:188-193.
26. Friedland IR, Shelton S, Paris M, Rinderknecht S, Ehretl S, Krisher K et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992; 12: 196-200.
27. Kleiman MB, Weinberg GA, Reynolds JK, Allen SD. Meningitis with beta-lactam-resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pedriatr Infect Dis J 1993; 12: 782-784.
28. Sloas MM, Barrett FF, Chesney PJ, English BJ, Hill BC, Tenover BC et al. Cephalosporin treatment failure in penicillin-and cephalosporin-resis-tant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992; 11: 662-666.
29. Alonso J, Madrigal V, Garcia-Fuentes M. Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. Pediatr Infect Dis J 1991; 10: 251-255.
30. Asensi F, Pérez Tamarit D, Otero MC, Gallego M, Llanes S, Abadis C et al. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus. Pediatr Infect Dis J 1989; 8: 895.
31. Asensi F, Otero MC. Pérez-Tamarit D, Rodríguez Escribano I, Cabedo JL, Gresa S et al. Risck/benefits in the treatment with imipenem-cilastatin of meningitis caused by penicillin-resistant pneumococcus in children. J Chemother 1993; 5: 133-134.
32. Catalán MJ, Fernández JM, Vázquez A, Varela de Seijas E. Suárez A, Bernaldo de Quirós C. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis 1994; 18: 756-769
33. Canton E. Cefotaxime breakpoint for Streptococcus pneumoniae. Antimicrob Agents Chemother 1993; 37: 616-617.
34. Klugamn KP. Pneumococcal resistance to third generation cephalosporins: clinical, laboratory and moiecular aspects. Intern J Antimicrob Agents 1994; 4: 63-67.
35. Liñares J, Tubau F. Meningitis neumococica y cefalosporinas de tercera generación. Enferm Infec Microbiol Clin 1996; 14: 1-6.
36. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992; 146: 920-923.
37. Pallarés R, Liñares J, Vadillo M, Cabellos C, Manresa F, Fernández-Viladrich P et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain, N Engl J Med 1995; 333: 474-480.
38. Klugman KP. The clinical relevance of in vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-adquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. J Antimicrob Chemother 1996; 38 (Supl A): 133-140,
39. Klugman K, Goldstein F, Kohno S, Baquero F. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci Clin Microbiol Infect 1997; 3 (Supl 1): 48-60.
40. Goldstein FW, Garau J. 30 years of penicillin-resistant S. pneumoniae: myth or reality. Lancet 1997; 350: 233-234.
41. Casal J. Antimicrobial susceptibility of Streptococcus pneumoniae: serotype distribution of penicillin-resistant strains in Spain. Antimicrob Agents Chemother 1982; 22: 222-225.
42. Liñares J, Garau J, Domínguez C, Pérez JL. Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community acquired pneumococcal disease. Antimicrob Agents Chemother 1983; 23: 545-547.
43. Latorre C, Juncosa T, Sanfeliu I. Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in children's hospital in Barcelona, Spain. Anlimicrob Agents Chemother 1985; 28: 357-359.
44. Garaía-Leoni ME, Cercenado E, Rodeño P, Bernaldo de Quirós JCL, Martínez-Hernández E, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992; 14: 427-435.
45. Bouza E, Muñoz P. Penicillin-resistant pneumococci in adult disease with especial reference to AIDS patients. Microb Drug Resistance 1995; 1:9-28.
46. García de Lomas J y Grupo Español de Vigilancia de Patógenos Respiratorios. Situación epidemiológica actual y resistencia de los patógenos respiratorios en nuestro país. Med Clin (Barc) 1998; 110 (Supl): 44-51.
47. Fenoll A. Informe del laboratorio de referencia de neumococos 1990-1993. Boletín Epidemiológico y Microbiológico 1994; 2: 21-40.
48. Grunenberg, Felmingham and the Alexander project group GR Micro Ltd, London The Alexander Project 1995. International Surveillance of Antimicrobial Resistance amongst Community-Adquired Lower Respiratory Tract Pathogens [resumen E-101]. Toronto, Canadá: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1997.
49. Fernández-Viladrich P, Cabellos C, Pallarés R, Tubau F, Martínez-Lacasa J, Liñares J. High dose of cefotaxime in the treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibility to third-generation cephalosporins, Antimicrob Agents Chemother 1996; 40: 218-220.
50. McDougal LK, Rasheed JK, Biddle JW, Tenover FC. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrob Agents Chemother 1995; 39: 2,282-2.288.
51. Liñares J. Antibiotic resistant pneumococci in the 1990s: an overview in Spain. En: Streptococcus pneumoniae Molecular Biology and Mechanisms of Disease-Update for the 1990s. Lisboa: 1996; 57-58.
52. a ed.). Approved Standard NCCLS. Document M7-A3 Villanova Pa: NCCLS, 1993.
53. Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical idolates by use of the E Test. J Antimicrob Chemother 1994; 32: 159-163
54. Krisher KK, Linscott A. Comparision of three comercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae. J Antimicrob Chemother 1994; 32: 2.242-2.245.
55. Friedland IR, Shelton S, McCracken GH. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test. J Antimicrob Chemother 1994; 32: 274-275.
56. Tenover FC, Swenson J, Ferraro MJ, Hindler J, Jorgensen J, Murray P. Cefuroxime screening test for pneumococci. J Clin Microbiol 1993; 31: 1.619-1.621.
57. Dowson C, Hutchison A, Brannigan JA, George RC, Hansman D, Liñares J et al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1989; 86: 8.842-8.846.
58. Muñoz R, Coffey TJ, Daniels M, Dowson CG, Labile G, Casal J et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-306.
59. Negri MC, Morosini MI, Loza E, Baquero F. In vitro selective antibiotic concentrations of β-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother 1994; 38: 122-125.
60. Baquero F. Trends in antibiotic resistance of respiratory pathogens an analysis and comentary on a collaborative surveillance study. J Antimicrob Chemother 1996; 38 (Supl A): 117-132.
61. Tomasz A, The pneumococcus at the gates. N Engl J Med 1995; 33: 514-515.
62. Alcaide F, Liñares J, Pallarés R, Carratalá J, Benítez MA, Gudiol F et al. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 1995; 39; 2.243-2.247.
63. Baquero F and the Task Force of the General Direction for Health Planning of the Sapnish Ministry of Health. Antibiotic resistance in Spain: What can be done? Clin Infect Dis 1996; 23: 819-823.
64. Kristinsson KG, Hjálmarsdóttir MA, Gudnanson Th. Epidemiology of penicillin - resistant pneumococci in Iceland: hope for the future? San Francisco, California: 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995.
65. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K et al. and the Finnish Study Group for Antimicrobial Resistance. The effect of changes in the consumption of macrolide antibiotics on erithromycin resistance in group A stretococci in Finland. N Engl J Med 1997; 337: 441-446.